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Metastasis accounts for a majority of cancer death. One key feature during metastasis is epithelial-mesenchymal
transition (EMT), which is regulated by transcription factors such as Snail and Twist. In non-malignant cells,
Snail has a short half-life and is degraded via ubiquitination, but its stability is increased in cancer cell.
However, the mechanism by which Snail escapes ubiquitination and degradation remains unknown. Recently,
we found that Dub3 is a deubiquinase of Snail. Most importantly, we determined that Dub3 responded to
extracellular signals such as IL-6, and that the resultant signaling prevented Snail degradation, and promoted
cancer growth, invasion, and migration. In this highlight, we present a concise picture of how the transcription
factor Snail is regulated by ubiquitination in cancer cells, the role of Dub3 in this process, and its potential use as
a treatment target.
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The ubiquitination of Snail
Metastasis accounts for 90% of cancer deaths [1]. In order
to establish new growth at a distant location, cancer cells
undergo invasion, intravasation, extravasation, and metastatic
colonization [2-4]. During this process, EMT is necessary for
cancer cells to lose their original intercellular adhesion and
initially adopt an increased motility [5, 6]. Similar to the
establishment of gestation layers by embryological cells,
cancer cells undergoing EMT re-overexpress transcription
factors such as Slug, Twist, and Snail, which repress proteins
such as cadherin, claudin, integrin, cytokine, as well as
others [5, 7]. Among these molecular triggers, Snail, a zinc
finger protein family member, has been widely

acknowledged for its role in EMT [5, 8-10]. Clinically, Snail
expression is associated with resistance to chemotherapy,
decreased survival, high recurrence rates and a poor
prognosis [11-13]. In accordance with its profound role in
development, Snail has a short half-life and is tightly
regulated by extracellular signaling, induced phosphorylation
and degradation through ubiquitination [14].
The ubiquitination proteasome pathway is one approach
utilized by cells to degrade targeted protein in eukaryotic cell
[5]
. During this process, ubiquitin, a 76 aminoacid peptide,
initially forms a thio-ester bond with the ubiquitin activating
enzyme (E1) and then is transferred to a ubiquitin
conjugating enzyme (E2). Subsequently, a ubiquitin ligating
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Figure 1. The ubiquitination regulation of Snail. Snail is degraded by several E3 ligase including β-TRCP1, Fbxl14,
Fbxl5, FBXO11 and Fbxo45. By contrast, Dub3 deubiquitinates Snail and prevents snail degradation through two axis: (1)
the IL-6/Dub3/Snail axis: the extracellular IL-6 signal leads to increased Dub3 activity; (2) CDK4/6/Dub3/Snail axis: CDK4/6
phosphorylates Dub3 at Ser41. Dub3 is responsible for EMT, cancer stem cell like traits, and invasiveness through Snail
stabilization.

enzyme (E3) catalyzes the formation of a covalent bond
between ubiquitin and a lysine residue on the target protein,
which then becomes susceptible to proteasomal degradation
[15]
. Snail’s ubiquitination and degradation are controlled by
several F-box ligases, including β-TRCP1/Fbxw1, Fbxl14,
Fbxl5, Fbxo11, and Fbxo45 [16-22] (Figure 1).
β-TRCP1/Fbxw1 is one of the best-characterized Snail E3
ligase. To initiate the even, phosphorylation of Snail by
GSK3β on residues S104 and S107 promotes Snail
localization to the cytoplasm; additional phosphorylation
events by GSK3β on the S96 and S100 residues generate the
β-TRCP1 phosphodegron [17]. Fbxl14, a cytoplasmic F-box
protein, shares the same lysine residues as β-TRCP1 in the
Snail N-terminal domain: K98, K137 and K146 and through
these associations ligates ubiquitin to Snail [21]. Through
global shRNA screening of F-box proteins, Fbxl5 was
identified as targeting Snail. Fbxl5 is localized
predominantly in the nucleus. Interestingly, Fbxl5 interacts
with the Snail C-terminus, the region involved in binding to
the E-box sequence while it polyubiquitinates Snail on its

N-terminal residues K85 and K146 as well as on its
C-terminal residue K234 [18]. In addition, Fbxl5-induced
Snail down-regulation is impaired by post-translational
modifications that prevent nuclear export, such as Lats2
phosphorylation [23]. Fbxo11 is another ubiquitin ligase that
targets the SNAG domain of Snail [19,24]. Whether Snail
degradation by Fbxo11 is dependent on S11 phosphorylation
by the PKD1 is controversial and needs confirmation. The
role of PKD1 –induced Snail phosphorylation is complex
since PKD1 can either inhibit or enhance Snail
transcriptional repression [25, 26]. Fbxo45 is an atypical F-box
protein induced by estrogen [27]. Fbxo45 interacts with Snail
through its F-box domain. Surprisingly, several of these E3
ligases interacts as well with Slug, Zeb1 and Twist such as
β-TRCP1, Fbxl14 and Fbxo45 while only Fbxl5 specifically
interacts with Snail. Previously, we found that the expression
of Snail can be stabilized by NF-κB at both transcriptional
and post-translational levels, to downregulate the expression
of E-cadherin and facilitate EMT [22, 28].
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The deubiquitination of Snail
One way to counteract this E3 ligase-mediated protein
degradation is through deubiquitinase, which removes the
ubiquitin moieties from target proteins and increases their
stability [29]. Deubiquitinase enzymes (DUBs) are classified
as UCH, USP, JAMM, OTU, and Ataxin-3/Josephin group.
Growing evidence shows that DUBs are essential for the
regulation of many cellular functions including transcription,
DNA repair, apoptosis and cell cycle progression [30]. Dub3
belongs to the USP group. Whereas Dub1 and Dub2 were
identified in mice, Dub3 is their human counterpart [31]. This
family of growth-regulatory deubiquitinating enzymes are
immediate-early genes and are induced rapidly and
transiently in response to cytokine stimuli [32]. Within last
few years, the role of Dub3 has emerged as an important
deubiquitinase in DNA repair, cell proliferation,
transcriptional factor regulation and tumor metastasis. For
example, by deubiquitinating histones H2A and H2B, Dub3
impedes the recruitment of DNA repair factors such as
53BP1 and BRCA1 and cripple the DNA damage response
that occurs with genotoxic stress [33]. By decreasing the
turnover rate of cdc25A phosphatase, Dub3 facilitates the
G1/S transition and promote cancer cell proliferation [34,35].
Dub3 also regulate YAP/TAZ activity by controlling the
stability of the E3 ligase ITCH, the LATS kinases and the
AMOT family proteins [36]. Using siRNA library screen
targeting the 99 known or putative DUBs, we identified
Dub3 is a deubiquitinase of Snail. Dub3 stabilizes Snail via
deubiqutination, downregulating E-cadherin expression and
promoting EMT [37, 38]. The interaction of Snail with Dub3 is
mediated at the N-terminal region of Snail, which holds the
SNAG domain and is the most common binding site for E3
[38]
. Expression of Dub3 blocked Snail degradation mediated
by the E3 ligases Fbxl14 and Fbxw1/β -TRCP1 [38].
Functionally, we found that the expression of Dub3 in breast
cancer cell lines not only downregulates markers of luminal
type of breast cancer, but also upregulates molecules
associated with BLBC [38]. Knockdown of Dub3 inhibits
migration, invasion and cancer stem cell (CSC)-like
characteristics in cells by downregulating of Snail. By
contrast, ectopic expression of Dub3 induces EMT through
an upregulation of Snail. Most importantly, we found that
depletion of Dub3 not only dampened spontaneous lung
metastasis but also inhibited tumor recurrence. Clinically,
Dub3 overexpression predicts a shortened relapse-free
survival and higher probability of distant metastasis. These
results strongly suggest that Dub3 can be a therapeutic target.
IL-6, a major cytokine present in the tumor
microenvironment, can induce EMT and promote metastasis

through the STAT3 signaling pathway in breast cancer, head
and neck cancer and pancreatic cancer [39]. Increased IL-6
level predicts tumor recurrence, a poor response to
chemotherapy, poor survival, and tumor metastasis [40]. IL-6
is also identified as a major cytokine secreted by BLBC cells
and is essential for the CSC-like characteristic of BLBC [41].
Interestingly, Dub3 activity and expression, at both the
mRNA and protein levels, can be induced by IL-6 through
the JAK/STAT3 signaling pathway [31, 38, 39]. Consistent with
this, we also found that IL-6 rapidly induces Dub3
expression, exerting a maximum effect at 2hr [38].
Dub3-knockdown not only reduced the endogenous level of
Snail but also blocked IL-6-induced Snail stabilization and
invasion. Thus, DUB3 could be a missing bridge between the
extracellular signaling in the tumor environment and
intracellular changes in genomic expression, and explains
how tumor-promoting inflammation can facilitate cancer
metastasis. These data delineate a key role by Dub3 in
connecting extracellular inflammatory signals to invasion,
CSC-like traits, and drug resistance.
Considering the crucial role of Dub3 in triggering EMT
and metastasis, we screened several Dub3 inhibitors and
found that WP1130 could bind to the catalytic site of Dub3.
In vitro, WP1130 inhibited cell migration, invasion, and
mammosphere formation, whereas in vivo, tumor growth
decreased significantly after treatment [38]. By blocking the
interaction of Dub3 and Snail, WP1130 prevents the
deubiquitination of Snail, thereby blocking cancer invasion,
migration, and the establishment of CSC-like properties.
Concurrently, palbociclib, a specific inhibitor of CDK4/6,
was reported to decrease Snail stability in a Dub3-dependent
manner [37]. CDK4/6 phosphorylates Dub3 at Ser41, a crucial
site for Dub3 activity in the regulation of Snail’s stability [37].
By acting on the CDK4/6-Dub3-Snail axis, palbociclib
reduced cancer cell migration and metastasis in vitro and in
vivo. In both cases, the ultimate target was the Dub3-Snail
interaction, suggesting critical role of Dub3-Snail axis in
cancer progression and metastasis (Figure 1).
Conclusion
Snail has been well acknowledged for its importance in
mediating EMT and tumor metastasis. Its stability is crucial
for cancer progression and metastasis. We have identified
Dub3 as the key regulator of Snail and the missing link
between extracellular signaling from sources such as IL-6 in
tumor environment, and the gene expression changes in cells
that promote cancer. In addition, we exploited Dub3’s value
as a therapeutic target. WP1130 reduces cancer migration
and metastasis by inhibiting Dub3’s catalytic activity and
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thereby restores the ubiquitination-mediated degradation of
Snail. Based on Dub3’s dual role in regulating tumor growth
and metastasis, future clinical and pharmaceutical
investigations could be directed towards this specific
interaction of Dub3-Snail. Last but not least, while our study
indicated that Dub3 could counteract the function of
β-TRCP1 and Fbxl14 in regulating the degradation of Snail,
both β -TRCP1 and Fbxl14 could also influence the stability
of Slug, ZEB1 and Twist. Future research could explore
Dub3’s role in regulating these transcription factors [21,42,43].
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